MENU

CUE Cue Biopharma Forecast, Technical & Fundamental Analysis

a developer of biopharmaceuticals

Industry Biotechnology
CUE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
CUE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

CUE is expected to report earnings to fall 49.41% to -8 cents per share on March 12

Cue Biopharma CUE Stock Earnings Reports
Q4'24
Est.
$-0.09
Q3'24
Beat
by $0.01
Q2'24
Beat
by $0.08
Q1'24
Beat
by $0.04
Q4'23
Est.
$-0.28
The last earnings report on November 15 showed earnings per share of -17 cents, beating the estimate of -18 cents. With 161.67K shares outstanding, the current market capitalization sits at 66.20M.
A.I. Advisor
published General Information

General Information

a developer of biopharmaceuticals

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
40 Guest Street
Phone
+1 617 949-2680
Employees
53
Web
https://www.cuebiopharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AGFY35.543.54
+11.06%
Agrify Corporation
AIP10.140.15
+1.50%
Arteris
MDT82.73-0.19
-0.23%
Medtronic plc
RNST36.61-0.46
-1.24%
Renasant Corp
OLLI111.19-2.31
-2.04%
Ollie's Bargain Outlet Holdings

CUE and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CUE has been loosely correlated with DNLI. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if CUE jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CUE
1D Price
Change %
CUE100%
-4.13%
DNLI - CUE
39%
Loosely correlated
-1.68%
VCYT - CUE
36%
Loosely correlated
+2.05%
AXON - CUE
33%
Loosely correlated
-0.94%
AMRN - CUE
32%
Poorly correlated
-2.21%
ARRY - CUE
31%
Poorly correlated
-3.33%
More